Prathibha Surapaneni1, Robyn M Scherber2. 1. Department of Hematology and Oncology, Mays MD Anderson Cancer Center at UT Health San Antonio, Urschel Tower #U623, 7979 Wurzbach Rd., San Antonio, TX, 78229, USA. 2. Department of Hematology and Oncology, Mays MD Anderson Cancer Center at UT Health San Antonio, Urschel Tower #U623, 7979 Wurzbach Rd., San Antonio, TX, 78229, USA. scherber@uthscsa.edu.
Abstract
PURPOSE OF REVIEW: Myeloproliferative neoplasms (MPNs) have a high symptom burden that affects functional status, emotional well-being, and quality of life for patients. Symptom control continues to be a challenging therapeutic goal despite available pharmacologic interventions. The goal of this review is to detail recent efforts that have focused on non-pharmacologic interventions, such as wholistic or integrative medicine, as an adjunctive method to alter symptom burden in this population. RECENT FINDINGS: We discuss the ongoing physical, nutritional, and psychological interventional efforts which represent promising non-traditional interventions to date to help reduce symptom in MPN patients. In this article, we highlight the early promising data and importance of these various non-pharmacological interventions to dampen symptom burden and reduce disease-related inflammation. Nonpharmacologic interventions represent promising therapeutic strategies to alter traditional MPN treatment paradigms and improve MPN patient care.
PURPOSE OF REVIEW: Myeloproliferative neoplasms (MPNs) have a high symptom burden that affects functional status, emotional well-being, and quality of life for patients. Symptom control continues to be a challenging therapeutic goal despite available pharmacologic interventions. The goal of this review is to detail recent efforts that have focused on non-pharmacologic interventions, such as wholistic or integrative medicine, as an adjunctive method to alter symptom burden in this population. RECENT FINDINGS: We discuss the ongoing physical, nutritional, and psychological interventional efforts which represent promising non-traditional interventions to date to help reduce symptom in MPN patients. In this article, we highlight the early promising data and importance of these various non-pharmacological interventions to dampen symptom burden and reduce disease-related inflammation. Nonpharmacologic interventions represent promising therapeutic strategies to alter traditional MPN treatment paradigms and improve MPN patient care.
Authors: Robyn Scherber; Amylou C Dueck; Peter Johansson; Tiziano Barbui; Giovanni Barosi; Alessandro M Vannucchi; Francesco Passamonti; Bjorn Andreasson; Maria L Ferarri; Alessandro Rambaldi; Jan Samuelsson; Gunnar Birgegard; Ayalew Tefferi; Claire N Harrison; Deepti Radia; Ruben A Mesa Journal: Blood Date: 2011-05-02 Impact factor: 22.113
Authors: Robyn M Emanuel; Amylou C Dueck; Holly L Geyer; Jean-Jacques Kiladjian; Stefanie Slot; Sonja Zweegman; Peter A W te Boekhorst; Suzan Commandeur; Harry C Schouten; Federico Sackmann; Ana Kerguelen Fuentes; Dolores Hernández-Maraver; Heike L Pahl; Martin Griesshammer; Frank Stegelmann; Konstanze Doehner; Thomas Lehmann; Karin Bonatz; Andreas Reiter; Francoise Boyer; Gabriel Etienne; Jean-Christophe Ianotto; Dana Ranta; Lydia Roy; Jean-Yves Cahn; Claire N Harrison; Deepti Radia; Pablo Muxi; Norman Maldonado; Carlos Besses; Francisco Cervantes; Peter L Johansson; Tiziano Barbui; Giovanni Barosi; Alessandro M Vannucchi; Francesco Passamonti; Bjorn Andreasson; Maria L Ferrari; Maria L Ferarri; Alessandro Rambaldi; Jan Samuelsson; Gunnar Birgegard; Ayalew Tefferi; Ruben A Mesa Journal: J Clin Oncol Date: 2012-10-15 Impact factor: 44.544
Authors: Panagiota N Mitrou; Victor Kipnis; Anne C M Thiébaut; Jill Reedy; Amy F Subar; Elisabet Wirfält; Andrew Flood; Traci Mouw; Albert R Hollenbeck; Michael F Leitzmann; Arthur Schatzkin Journal: Arch Intern Med Date: 2007-12-10
Authors: C Marty; C Lacout; N Droin; J-P Le Couédic; V Ribrag; E Solary; W Vainchenker; J-L Villeval; I Plo Journal: Leukemia Date: 2013-04-05 Impact factor: 11.528
Authors: Hninyee Win; Samantha Russell; Betsy C Wertheim; Victoria Maizes; Robert Crocker; Audrey J Brooks; Ruben Mesa; Jennifer Huberty; Holly Geyer; Ryan Eckert; Ashley Larsen; Krisstina Gowin Journal: JMIR Form Res Date: 2022-03-31
Authors: Krisstina Gowin; Blake T Langlais; Heidi E Kosiorek; Amylou Dueck; Denise Millstine; Jennifer Huberty; Ryan Eckert; Ruben A Mesa Journal: Cancer Med Date: 2020-11-03 Impact factor: 4.452